| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3339774 | Allergologia et Immunopathologia | 2015 | 5 Pages |
Abstract
Despite recent advances in the treatment of XLA, these patients still suffer from severe complications. Associations between poor prognosis and clinical and some immunological characteristics of the patients may help physicians to select poor prognoses patients at higher risk of mortality to develop prevention strategies for them.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
H. Abolhassani, A. Hirbod-Mobarakeh, S. Shahinpour, M. Panahi, P. Mohammadinejad, B. Mirminachi, M.S. Shakari, B. Samavat, A. Aghamohammadi,